Skip to content

Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong

Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong: a Randomised Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03879889
Enrollment
210
Registered
2019-03-19
Start date
2017-02-01
Completion date
2019-07-31
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Tobacco

Keywords

Smoking reduction, Randomised controlled trial, Motivational interview, Nicotine replacement therapy, Environmental tobacco smoke exposure, Paediatrics, Children

Brief summary

A randomized controlled trial to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong.

Detailed description

This is a single blinded randomized controlled trial aiming to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong. This trial consists of a 24-week intervention period. Eligible families will be randomly assigned to either intervention group or control group. Smoking parent(s) in intervention group will be given face-to-face counselling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of NRT and monthly phone follow-up for counselling and support. Smoking parent(s) in control group will be given standard advice and information on smoking cessation.

Interventions

DRUGNicotine patch

Four weeks of nicotine patch will be provided at the first contact, which will be prescribed using the guidelines based on the subject's daily cigarette consumption. At week-4 visit, four more weeks of NRT will be provided.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Research study personnel who will conduct the data collection on outcome measures will be blinded to the group assignment. The researchers who will conduct the data analysis will also be blinded the group assignment.

Intervention model description

A single blinded randomized controlled trial aiming to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong. This trial consists of a 24-week intervention period. Eligible families will be randomly assigned to either intervention group or control group. Smoking parent(s) in intervention group will be given face-to-face counselling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of NRT and monthly phone follow-up for counselling and support. Smoking parent(s) in control group will be given standard advice and information on smoking cessation.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Ethnic Chinese family with children aged younger than 18 years of age. * Children who are admitted to the paediatric inpatient units or attend the paediatric specialist clinic at the Prince of Wales Hospital. * Children with at least one custodial smoking parent who is living with them. * Written informed consent obtained from parents.

Exclusion criteria

* Families not residing in Hong Kong. * Children in foster care. * Children with unclear custody. * Smoking paediatric patients. * Presence of smoking household members apart from the parents. * Smoking parent who is contraindicated to use nicotine replacement therapy.

Design outcomes

Primary

MeasureTime frameDescription
Validated successful smoking reduction rateWeek-24Urinary cotinine validated parental successful smoking reduction rate at week-24
Self-reported parental successful smoking reduction rate at week-24Week-24Self-reported reduction of daily cigarette consumption by 50% or more compared with baseline

Secondary

MeasureTime frameDescription
Urinary cotinine validated parental smoking cessation rate at week-24Week-24Urinary cotinine validated parental smoking cessation rate at week-24
Parental self-reported smoking reduction rate of cigarette consumptionWeek-24Parental self-reported smoking reduction rate of cigarette consumption
Parental self-reported smoking cessation rate of cigarette consumptionWeek-24Parental self-reported 7-day point-prevalence tobacco abstinence
Change in children's urinary cotinine level from baseline to week-24Week-24Change in children's urinary cotinine level from baseline to week-24

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026